Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Five Prime and GSK join to discover drugs for skeletal muscle disorders

Aug. 5, 2010

Mitsubishi Tanabe transfers Kerlong marketing rights to sanofi-aventis

Aug. 4, 2010

Oxygen signs CRADA with U.S. navy to study decompression sickness therapy

Aug. 4, 2010

Seattle Genetics and Genentech expand antibody-drug conjugate agreement

Aug. 4, 2010

Lexicon reacquires rights to several serotonin synthesis inhibitors from Symphony Icon

Aug. 4, 2010

Cornerstone and Alitair collaborate on drug development for respiratory diseases

Aug. 4, 2010

Servier to develop and commercialize Osteologix's NBS-101 outside U.S.

Aug. 3, 2010

Stellar Pharma and Inibsa sign agreement to distribute and sell Uracyst in Spain

Aug. 2, 2010

Actient Pharmaceuticals acquires six pharmaceuticals from UCB

Aug. 2, 2010

National Eye Institute awards Lpath grant to develop sonepcizumab for wet AMD

Aug. 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...